TELA Bio Statistics
Want to see TELA full AI Analyst Report?
TELA Bio (TELA) Stock Statistics & Valuation Metrics
Total Valuation
TELA Bio has a market cap or net worth of $34.44M. The enterprise value is $100.51M.
- Market Cap
- $34.44M
- Enterprise Value
- $100.51M
Share Statistics
TELA Bio has 45,188,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 45,188,230
- Owned by Insiders
- 5.12%
- Owned by Institutions
- 57.97%
Financial Efficiency
TELA Bio’s return on equity (ROE) is -6.15 and return on invested capital (ROIC) is -53.21%.
- Return on Equity (ROE)
- -6.15
- Return on Assets (ROA)
- -0.48
- Return on Invested Capital (ROIC)
- -53.21%
- Return on Capital Employed (ROCE)
- -0.53
- Revenue Per Employee
- 368.23K
- Profits Per Employee
- -178.12K
- Employee Count
- 218
- Asset Turnover
- 0.99
- Inventory Turnover
- 2.35
Valuation Ratios
The current PE Ratio of TELA Bio is -1.05. TELA Bio’s PEG ratio is -0.05.
- PE Ratio
- -1.05
- PS Ratio
- 0.45
- PB Ratio
- -1.83
- Price to FCF
- -1.03
- Price to Operating Cash Flow
- -1.32
- PEG Ratio
- -0.05
Income Statement
In the last 12 months, TELA Bio had revenue of 80.28M and earned -38.83M in profits. Earnings per share was -0.83.
- Revenue
- 80.28M
- Gross Profit
- 54.34M
- Operating Income
- -33.76M
- Pretax Income
- -38.60M
- Net Income
- -38.83M
- EBITDA
- -32.35M
- Earnings Per Share (EPS)
- -0.83
Cash Flow
In the last 12 months, operating cash flow was -34.11M and capital expenditures -276,000, giving a free cash flow of -34.39M billion.
- Operating Cash Flow
- -34.11M
- Free Cash Flow
- -34.39M
- Free Cash Flow per Share
- -0.60
Dividends & Yields
TELA Bio pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -97.55%
- Earnings Yield
- -93.06%
Stock Price Statistics
- Beta
- 0.96
- 52-Week Price Change
- -33.90%
- 50-Day Moving Average
- 1.03
- 200-Day Moving Average
- 0.84
- Relative Strength Index (RSI)
- 39.15
- Average Volume (3m)
- 217.25K
Important Dates
TELA Bio upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 10, 2026
- Next Earnings Date
- Mar 25, 2027
- Ex-Dividend Date
- ―
Financial Position
TELA Bio as a current ratio of 4.20, with Debt / Equity ratio of 881.56%
- Current Ratio
- 4.20
- Quick Ratio
- 3.59
- Debt to Market Cap
- 1.00
- Net Debt to EBITDA
- -0.15
- Interest Coverage Ratio
- -6.44
Taxes
In the past 12 months, TELA Bio has paid 230.00K in taxes.
- Income Tax
- 230.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
TELA Bio EV to EBITDA ratio is -2.09, with an EV/FCF ratio of -2.00.
- EV to Sales
- 0.88
- EV to EBITDA
- -2.09
- EV to Free Cash Flow
- -2.00
- EV to Operating Cash Flow
- -2.02
Balance Sheet
TELA Bio has $22.66M in cash and marketable securities with $56.30M in debt, giving a net cash position of -$33.63M billion.
- Cash & Marketable Securities
- $22.66M
- Total Debt
- $56.30M
- Net Cash
- -$33.63M
- Net Cash Per Share
- -$0.74
- Tangible Book Value Per Share
- -$0.44
Margins
Gross margin is 67.19%, with operating margin of -43.17%, and net profit margin of -53.57%.
- Gross Margin
- 67.19%
- Operating Margin
- -43.17%
- Pretax Margin
- -53.10%
- Net Profit Margin
- -53.57%
- EBITDA Margin
- -42.07%
- EBIT Margin
- -43.04%
Analyst Forecast
The average price target for TELA Bio is $1.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $1.75
- Price Target Upside
- 124.36% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- 1.46%
- EPS Growth Forecast
- 15.79%
Scores
- Smart Score
- 8
- AI Score
- 48

